Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


26.11.2018

2 Am J Hematol
3 Ann Hematol
1 Biochem Biophys Res Commun
2 Blood
2 BMC Cancer
2 Bone Marrow Transplant
1 Leuk Lymphoma
5 Leuk Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. POIRE X, Labopin M, Polge E, Blaise D, et al
    Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission.
    Am J Hematol. 2018 Nov 19. doi: 10.1002/ajh.25355.
    PubMed     Text format     Abstract available

  2. BARRETT A, Catherwood M, Thornton P, Murphy P, et al
    Transformation of MDS/MPN-RS-T to AML: Trisomy 13, resistant thrombocytosis and transient disease control with oral busulfan therapy.
    Am J Hematol. 2018;93:E16-E17.
    PubMed     Text format    


    Ann Hematol

  3. ISHIDA H, Iguchi A, Aoe M, Takahashi T, et al
    Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
    Ann Hematol. 2018 Nov 17. pii: 10.1007/s00277-018-3554.
    PubMed     Text format     Abstract available

  4. DE BARROS S, Vayr F, Despas F, Strumia M, et al
    The impact of chronic myeloid leukemia on employment: the French prospective study.
    Ann Hematol. 2018 Nov 17. pii: 10.1007/s00277-018-3549.
    PubMed     Text format     Abstract available

  5. GARCIA-GUTIERREZ V, Milojkovic D, Hernandez-Boluda JC, Claudiani S, et al
    Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
    Ann Hematol. 2018 Nov 16. pii: 10.1007/s00277-018-3507.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. ZHOU H, Shen J, Hu Z, Zhong X, et al
    Leukemia inhibitory factor promotes extracellular matrix synthesis in degenerative nucleus pulposus cells via MAPK-ERK1/2 signaling pathway.
    Biochem Biophys Res Commun. 2018 Nov 13. pii: S0006-291X(18)32416.
    PubMed     Text format     Abstract available


    Blood

  7. RAVANDI F
    How I treat Philadelphia chromosome positive acute lymphoblastic leukemia.
    Blood. 2018 Nov 15. pii: blood-2018-08-832105. doi: 10.1182/blood-2018-08-832105
    PubMed     Text format     Abstract available

  8. BROWN P, Pieters R, Biondi A
    How I treat infant leukemia.
    Blood. 2018 Nov 20. pii: blood-2018-04-785980. doi: 10.1182/blood-2018-04-785980
    PubMed     Text format     Abstract available


    BMC Cancer

  9. WEN S, Niu Z, Xing L, Wang Y, et al
    CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report.
    BMC Cancer. 2018;18:1143.
    PubMed     Text format     Abstract available

  10. BERTAMINI L, Nanni J, Marconi G, Abbenante M, et al
    Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.
    BMC Cancer. 2018;18:1117.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  11. ALDOSS I, Pullarkat V
    Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD?
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0398.
    PubMed     Text format    

  12. GOWDA L, Shah M, Badar I, Bashir Q, et al
    Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs.
    Bone Marrow Transplant. 2018 Nov 16. pii: 10.1038/s41409-018-0392.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  13. HARADA K, Yanada M, Machida S, Kanamori H, et al
    Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.
    Leuk Lymphoma. 2018 Nov 20:1-10. doi: 10.1080/10428194.2018.1535115.
    PubMed     Text format     Abstract available


    Leuk Res

  14. ITONAGA H, Ota S, Ikeda T, Taji H, et al
    Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
    Leuk Res. 2018;75:50-57.
    PubMed     Text format     Abstract available

  15. ANDO N, Furuichi Y, Kasai S, Tamai M, et al
    Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.
    Leuk Res. 2018;75:36-44.
    PubMed     Text format     Abstract available

  16. VACHHANI P, Al Yacoub R, Miller A, Zhang F, et al
    Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience.
    Leuk Res. 2018;75:29-35.
    PubMed     Text format     Abstract available

  17. JAKOVIC L, Bogdanovic A, Djordjevic V, Dencic-Fekete M, et al
    The predictive value of morphological findings in early diagnosis of acute myeloid leukemia with recurrent cytogenetic abnormalities.
    Leuk Res. 2018;75:23-28.
    PubMed     Text format     Abstract available

  18. FRIES C, Burack WR
    A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia.
    Leuk Res. 2018;75:15-22.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: